Results 111 to 120 of about 12,705 (162)

Real-world evidence for repurposing hydralazine as a potential epigenetic modulator for psoriasis: a 16-year retrospective nationwide cohort study. [PDF]

J Transl Med
Wu SE, Wang WM, Hung CT, Chung CH, Chien WC, Yang BH.   +5 more
europepmc   +1 more source

Integrated Bioinformatics Identifies NLRP3 Inflammasome Hub Genes and Therapeutic Targets in Schizophrenia. [PDF]

Neuropsychiatr Dis Treat
Ma J, Cui Y, Li X, Liu R, Wang J, Liu M, Kong L, Ren Y.   +7 more
europepmc   +1 more source

Efficacy and Safety of Nifedipine Compared to Intravenous Hydralazine for Severe Hypertensive Disorders in Pregnancy: A Systematic Review and Meta-Analysis of Randmomized Controlled Trials. [PDF]

Med Sci (Basel)
Govindasamy V, Kamel MA, Volucke G, Javed A, Palchaudhuri U, Kazi SI, Albanna A, Akileh M, Mukherjee R, Nusrat R, Qaiser T, Elzain Hassan EI, Azhar MM, Hashmi TM, Ahmed M, Hasan A, Ahmed R.   +16 more
europepmc   +1 more source

Antihypertensive therapy for pregnancy hypertension and implications for fetal and neonatal heart rate monitoring: A systematic review of randomized trials and observational studies. [PDF]

Acta Obstet Gynecol Scand
Ganeshamoorthy A, Duke OF, Mistry HD, Bone JN, Vidler M, Abalos E, Badawy K, Khalil A, von Dadelszen P, Magee LA.   +9 more
europepmc   +1 more source

Assessment of Risk Factors for Vasoplegic Syndrome in Patients Undergoing Cardiac Surgery With Cardiopulmonary Bypass. [PDF]

Cureus
Meyer KA, Brink HL, Brannan SC, Lundgren SW, Lyden ER, Behlers QB.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Hydralazine

Reactions Weekly, 2021
  +8 more sources

Studies on hydralazine

European Journal of Clinical Pharmacology, 1976
The bioavailability of orally administered hydralazine was assessed in 4 healthy subjects after separate administration of a single oral or intravenous dose (0.3 mg-kg-1). Comparison of the areas under the serum concentration-time curves showed that 26-55% of the oral dose was available to the systemic circulation as unchanged drug.
openaire   +2 more sources

Pharmacokinetics of hydralazine, apparent hydralazine and hydralazine pyruvic acid hydrazone in humans.

Research communications in chemical pathology and pharmacology, 1980
Hydralazine is an antihypertensive vasodilator agent. Lack of specific assay techniques for its measurement have delayed elucidation of its pharmacokinetic profile. This study compares the plasma profiles of hydralazine, measured both by a specific and by a previously published nonspecific assay and of a major plasma metabolite, hydralazine pyruvic ...
A M, Shepherd, T M, Ludden, K D, Haegele, T, Talseth, J L, McNay   +4 more
openaire   +1 more source

Hydralazine

Reactions Weekly, 2016
  +7 more sources